ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 610459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 610459; 2) Community: the network communities that were significantly associated with the response to NSC 610459; 3) Molecule: the relationships between components within communities and NSC 610459; 4) MDR: the compounds that were significantly associated with the NSC 610459.

NSC Compound Enrichment Correlation
NSC 716089 Null 0.00313644776247642 0.066076697
NSC 172614 9H-Purin-2-amine, 9-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.00356954838698626 0.38504304
NSC 19441 FDA 0283 0.00356954838698626 0.32100183
NSC 698095 Null 0.00356954838698631 0.41128153
NSC 680721 5H-1,4,8,11-Benzotetrathiacyclotridecin- 13,14-dicarbonitrile, 2,3,6,7,9,10-hexahydro- 0.0035949310449002 0.04546952
NSC 63878 Cytarabine Hydrochloride AZ 0.00366577979610627 0.73791413
NSC 642324 Null 0.00366577979610627 0.67050508
NSC 673652 2-Ethylaminoestradiol 0.00366577979610627 0.17138874
NSC 678869 Benz[a]anthracene-6,6-dicarboxylic acid, 5,6,7,12- tetrahydro-2-methoxy-7,12-dioxo-, dimethyl ester 0.00366577979610627 0.11726501
NSC 683556 Camptothecin Derivative 0.00366577979610627 0.85600676
Total:64  Current:6    [First] [Prev] [Next] [Last]